HK1141465A1 - Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof - Google Patents

Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof

Info

Publication number
HK1141465A1
HK1141465A1 HK10107930.6A HK10107930A HK1141465A1 HK 1141465 A1 HK1141465 A1 HK 1141465A1 HK 10107930 A HK10107930 A HK 10107930A HK 1141465 A1 HK1141465 A1 HK 1141465A1
Authority
HK
Hong Kong
Prior art keywords
permissive
enzymatically
kits
formulations
amounts
Prior art date
Application number
HK10107930.6A
Other languages
English (en)
Inventor
Israel Nur
Roberto Meidler
Liliana Bar
Original Assignee
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38654579&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1141465(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omrix Biopharmaceuticals Ltd filed Critical Omrix Biopharmaceuticals Ltd
Publication of HK1141465A1 publication Critical patent/HK1141465A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
HK10107930.6A 2007-07-02 2010-08-19 Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof HK1141465A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US92953407P 2007-07-02 2007-07-02
EP07111565A EP2011524A1 (en) 2007-07-02 2007-07-02 Fibrin glue with a visualization agent
US7103108P 2008-04-09 2008-04-09
PCT/IB2008/052636 WO2009004573A1 (en) 2007-07-02 2008-07-01 Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof

Publications (1)

Publication Number Publication Date
HK1141465A1 true HK1141465A1 (en) 2010-11-12

Family

ID=38654579

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10107930.6A HK1141465A1 (en) 2007-07-02 2010-08-19 Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof

Country Status (10)

Country Link
US (2) US20100203033A1 (xx)
EP (3) EP2011524A1 (xx)
JP (2) JP5507453B2 (xx)
CN (2) CN101820927B (xx)
CA (1) CA2691972C (xx)
ES (2) ES2393939T3 (xx)
HK (1) HK1141465A1 (xx)
IL (1) IL202939A (xx)
MX (1) MX2010000343A (xx)
WO (1) WO2009004573A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2011524A1 (en) * 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent
JP5808898B2 (ja) * 2009-09-29 2015-11-10 一般財団法人化学及血清療法研究所 組織癒着防止剤
KR101786786B1 (ko) 2010-01-28 2017-10-18 옴릭스 바이오파머슈티컬스 리미티드 개선된 피브린 밀봉 방법
EP3506915B1 (en) * 2016-09-01 2024-03-06 Plas-Free Ltd Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders
EP3573674A1 (en) * 2017-01-30 2019-12-04 LifeCell Corporation Transglutaminase treated products
WO2020121289A1 (en) * 2018-12-12 2020-06-18 Omrix Biopharmaceuticals Ltd. Low concentrated protein compositions for preventing tissue adhesion
IL263679A (en) 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and ingredients for preventing tissue adhesion
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
WO2023119277A1 (en) * 2021-12-21 2023-06-29 Omrix Biopharmaceuticals Ltd. Highly soluble fibrinogen compositions
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2066429A1 (en) * 1989-09-12 1991-03-13 Mehmet C. Oz Laser tissue welding with dye enhanced solders
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
US5792835A (en) 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
EP0534178B1 (en) 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Improved tissue glue prepared by using cryoprecipitate
CZ280540B6 (cs) 1991-09-27 1996-02-14 Opperbas Holding B.V. Tkáňové lepidlo obsahující kryoprecipitát, způsob jeho výroby a použití aprotininu, proteázy z hadího jedu a batroxobinu pro jeho přípravu
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
AU4648697A (en) * 1996-09-23 1998-04-14 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US7009034B2 (en) * 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
US6121232A (en) 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
EP0856317A1 (en) 1997-01-31 1998-08-05 Omrix Biopharmaceuticals S.A. A stabilized mixture comprising fibrinogen
US20050049178A1 (en) * 1999-07-06 2005-03-03 Oberschwabenklinik Gmbh Agent for the occlusion of blood vessels
JP2002104996A (ja) * 2000-09-25 2002-04-10 Mochida Pharmaceut Co Ltd 色素含有止血用組成物
WO2002030446A2 (en) * 2000-10-13 2002-04-18 Baxter International Inc. Reduction or prevention of post-surgical adhesion formation with fibrinogen
EE05485B1 (et) 2001-05-21 2011-10-17 Omrix Biopharmaceuticals S.A. Plasmi(i)n(ogeen)i eemaldamine valgulahustest
IL162369A0 (en) * 2001-12-04 2005-11-20 Woolverton Christopher J Storage-stable fibrin sealant
US20070286881A1 (en) * 2005-07-14 2007-12-13 Brian Burkinshsw Method, composition and kit for treating degenerated disc disease and discogenic pain
EP2011524A1 (en) * 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent

Also Published As

Publication number Publication date
EP2170414A1 (en) 2010-04-07
JP5937129B2 (ja) 2016-06-22
JP2010531870A (ja) 2010-09-30
CN104707168A (zh) 2015-06-17
JP5507453B2 (ja) 2014-05-28
EP2011524A1 (en) 2009-01-07
US20180093010A1 (en) 2018-04-05
EP2170414B1 (en) 2012-08-29
CA2691972C (en) 2016-08-16
EP2508211A1 (en) 2012-10-10
EP2508211B1 (en) 2013-12-18
CN104707168B (zh) 2017-09-01
JP2014133747A (ja) 2014-07-24
CN101820927A (zh) 2010-09-01
CN101820927B (zh) 2015-04-22
US20100203033A1 (en) 2010-08-12
IL202939A (en) 2013-02-28
WO2009004573A1 (en) 2009-01-08
ES2451025T3 (es) 2014-03-26
MX2010000343A (es) 2010-04-30
ES2393939T3 (es) 2013-01-02
CA2691972A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
HRP20190378T1 (hr) Prolijekovi tetrahidrokanabinola, pripravci koji sadržavaju prolijekove tetrahidrokanabinola i postupci za njihovu uporabu
HK1141465A1 (en) Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof
EG25965A (en) Enzyme and fabric hueing agent containing compositions
EP2061476A4 (en) COMPOSITIONS WITH CDP-CHOLINE AND METHOD OF USE THEREOF
IL205317A0 (en) Compositions comprising electrochemically altered aqueous fluids and uses thereof
IL193297A0 (en) Imidazole-based compounds, compositions comprising them and methods of their use
IL200889A0 (en) Compositions and kits for treating influenza
EP2048195A4 (en) INORGANIC ORGANIC HYBRID COMPOSITION AND USE THEREOF
EP2153838A4 (en) ANTI-NOROVIRUS AGENT AND COMPOSITION COMPRISING SAME
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
GB0601143D0 (en) Uses, methods and compositions
PL2046289T3 (pl) Kompozycje i zestawy fenylefryny
ZA201000992B (en) Anti-viral compounds, compositions, and methods of use
EP2340297A4 (en) COMPOSITION, ITS MANUFACTURING METHOD AND USE
GB0706077D0 (en) Methods, Compositions and uses thereof
IL200387A0 (en) Heterocylic compounds, compositions comprising them and methods of their use
IL207639A0 (en) Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof
GB0819432D0 (en) Compound, composition and use
EP2285953A4 (en) RNA POLYPHOSPHATASE COMPOSITIONS, KITS AND THEIR USE
HK1149770A1 (en) Compositions, methods and kits
IL208087A0 (en) Topical ectoparasiticide compositions and uses thereof
EP2247303A4 (en) HEMOSTASE MODULATING COMPOSITIONS AND USES THEREFOR
PL2313442T3 (pl) Środki dyspergujące i ich zastosowanie
GB0624132D0 (en) Hair conditioning compositions
AU2009249106A8 (en) Arylsulfonamide compounds, compositions and methods of use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230701